Clarity in cell line development

Solentim to present with Celonic at Biotech Week Boston: new-look VIPS will also premiere at the trade booth

Solentim, a global leader in cell line development instrumentation, is pleased to announce it will be attending and exhibiting at Biotech Week Boston, taking place 9-12 September. Camille Evenou, Scientist in cell line development at Celonic AG (Basel, CH), a customer of Solentim, will be talking in the Cell Line Development Pre-Conference Symposiumat 12pm on …

Read more Solentim to present with Celonic at Biotech Week Boston: new-look VIPS will also premiere at the trade booth

Solentim in the Press: “Increasing HD-BIOP3 Seeding Efficiencies using the VIPS” GEN Tutorial

Read this new Bioprocessing Tutorial in the latest edition of Genetic Engineering News (GEN). In this educational piece, scientists at Solentim demonstrate the ways in which they have systematically been able to increase viability, recovery and outgrowth of single cells following single cell isolation in the cell line development process. As part of this, the …

Read more Solentim in the Press: “Increasing HD-BIOP3 Seeding Efficiencies using the VIPS” GEN Tutorial

Solentim reports continued strong growth in 2019

NEWS – Bournemouth, UK – 8th August 2019: Solentim, the innovator and World leader in Cell Line Development instrumentation, is pleased to announce that it achieved very strong revenue growth and financial results for the first half of 2019. Commenting on the performance, Dr Ian Taylor, Chief Commercial Officer noted “Our results are in line with …

Read more Solentim reports continued strong growth in 2019

Solentim in the Press: “Fast-Tracking Cell-Line Development”, BioCompare

“Protein pharmaceuticals represent a multibillion-dollar market, but deciphering the most suitable biotherapeutic-producing cell lines is a substantial manufacturing bottleneck”, writes Lauren Tanabe for a recent article published by BioCompare. CHO cells have been the expression system of choice for producing biological therapies for several decades; they are accepted by the FDA, easy to work with, …

Read more Solentim in the Press: “Fast-Tracking Cell-Line Development”, BioCompare

Solentim, along with partner ATUM, will present at the forthcoming Cell Line Development and Engineering US Conference

Solentim, a global leader in cell line development instrumentation, will be speaking and exhibiting at the Cell Line Development and Engineering Conference US, which returns to San Francisco later this month. We are excited that our co-marketing and collaboration partner ATUM will also be speaking and exhibiting at the event. The aim of the conference …

Read more Solentim, along with partner ATUM, will present at the forthcoming Cell Line Development and Engineering US Conference